Kyle R. Brimacombe
National Institutes of Health(US)National Center for Advancing Translational Sciences(US)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Cancer, Hypoxia, and Metabolism, Drug Transport and Resistance Mechanisms, Cancer, Lipids, and Metabolism, Medical Imaging Techniques and Applications
Most-Cited Works
- → Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19(2020)958 cited
- → Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis(2012)816 cited
- → Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors(2016)598 cited
- → A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate(2016)578 cited
- → Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo(2015)417 cited
- Assay Guidance Manual [Internet](2004)
- → Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells(2008)268 cited